发明公开
- 专利标题： SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR
- 专利标题（中）： 磺酰基化合物作为CB2受体调节剂
-
申请号： EP07813203.2申请日： 2007-07-23
-
公开(公告)号： EP2081905A2公开(公告)日： 2009-07-29
- 发明人: BERRY, Angela , CIRILLO, Pier Francesco , HICKEY, Eugene Richard , RIETHER, Doris , THOMSON, David S. , ERMANN, Monika , JENKINS, James Edward , MUSHI, Innocent , TAYLOR, Malcolm , CHOWDHURY, Chandana , PALMER, Christopher Francis , BLUMIRE, Nigel
- 申请人： Boehringer Ingelheim International GmbH , Boehringer Ingelheim Pharma GmbH & Co. KG
- 申请人地址： Binger Strasse 173 55216 Ingelheim DE
- 专利权人： Boehringer Ingelheim International GmbH,Boehringer Ingelheim Pharma GmbH & Co. KG
- 当前专利权人： Boehringer Ingelheim International GmbH,Boehringer Ingelheim Pharma GmbH & Co. KG
- 当前专利权人地址： Binger Strasse 173 55216 Ingelheim DE
- 代理机构： Hammann, Heinz
- 优先权： US820622P 20060728
- 国际公布： WO2008014199 20080131
- 主分类号： C07D215/38
- IPC分类号： C07D215/38 ; C07D217/22 ; C07D213/75 ; C07D231/40 ; C07D233/88 ; C07D235/30 ; C07D261/14 ; C07D261/20 ; C07D263/28 ; C07D263/58 ; C07D277/56 ; C07D277/60 ; C07D277/62 ; C07D285/08
摘要：
Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
公开/授权文献
- EP2081905B1 SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR 公开/授权日：2012-09-12
信息查询
